When it comes to cancer, there's innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it allowed pharmaceutical companies like Pfizer Inc (NYSE:PFE) and Moderna Inc (NASDAQ:MRNA) to develop their groundbreaking vaccines in record time. By the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered.

Mainz Biomed N.V. (NASDAQ:MYNZ) to revolutionize colorectal cancer diagnostics and prevention.

CRC has been recognized as the second most lethal cancer both in the...